Peter W. Sonsini Insider Trading $SURF Surface Oncology, Inc.

Get the latest insider transactions of Peter W. Sonsini. Peter W. Sonsini is 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Marker Therapeutics, Inc. ($MRKR) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX).